Lcz696 targets blood pressure and arterial stiffness
Monday, August 31, 2015 - 09:10
in Health & Medicine
The combination drug valsartan/sacubitril known as LCZ696 significantly reduced aortic systolic blood pressure and pulse pressure compared to the standard angiotensin receptor blocker (ARB) olmesartan in patients with hypertension.